Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Extended duration local anesthetic formulation

A kit and solution technology, applied in the field of long-acting local anesthetics, can solve problems such as death

Active Publication Date: 2018-11-23
VENTIS PHARMA
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Bupivacaine and etidocaine have been reported to provide major nerve block within 3 to 12 hours; unfortunately, each of these local anesthetics is also highly cardiotoxic and may be due to vascular absorption resulting in death
Some existing products use high concentrations (approximately 2%) of bupivacaine, which also causes death

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extended duration local anesthetic formulation
  • Extended duration local anesthetic formulation
  • Extended duration local anesthetic formulation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0061] The disclosed subject matter will now be described in detail, which are illustrated in the accompanying drawings. The scope of the inventive concepts disclosed herein is limited only by the claims; numerous alternatives, modifications and equivalents are encompassed. For the purpose of clarity, technical material that is known in the technical fields related to the embodiments has not been described in detail so as not to unnecessarily obscure the description.

[0062]In one aspect of the inventive concepts disclosed herein, there is provided a mixture of tetracaine and a short-acting local anesthetic selected from a class of anesthetics that begins in less than 5 minutes after injection Provides local or regional pain relief that lasts for more than 24 hours. In one aspect, the mixture is produced at the time of application from a solution comprising a short-acting local anesthetic and a tetracaine powder formulation. A powder formulation of tetracaine allows for the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An extended duration anesthetic includes a short duration local anesthetic in a dilute solution and a long duration local anesthetic. The long duration local anesthetic is maintained in a powdered form until the time of administration. Premeasured quantities of the dilute solution and powdered long duration local anesthetic in a kit allow for quick preparation of a solution with desired concentrations of both short duration local anesthetic and long duration local anesthetic at the time of administration.

Description

technical field [0001] Embodiments of the application disclosed herein relate generally to local anesthetics, and more particularly to long-acting local anesthetics for producing prolonged analgesic effects during surgical procedures. Background technique [0002] Local anesthesia refers to any technique that induces anesthesia in a specific part of the body, usually with the aim of inducing local analgesia or localized analgesia. Regional anesthesia aims to numb a large part of the body, such as an area of ​​the arm, leg, or torso, by blocking the function of a specific nerve or nerves. Typically, various local anesthetics are injected into the surgical site or into sites adjacent to specific nerves to provide pain relief to specific areas. Current medications typically provide pain relief between 2-18 hours. Proprietary formulations of liposomal bupivacaine sold under the trade mark Exparel claim to have a duration of up to 72 hours, but such durations are generally not ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K9/14A61K31/24A61K31/135A61K31/137A61K31/165A61K31/166A61K31/216A61K31/245A61K31/445
CPCA61K9/0019A61K9/14A61K9/08A61K31/137A61K31/445A61K31/4458A61K31/245A61K47/02A61P23/02A61P43/00B65D81/3266A61J1/2093A61K31/573A61K2300/00A61K45/06
Inventor J.波尔森L.斯坦菲尔德L.沃尔兹
Owner VENTIS PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products